Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

terazosin hydrochloride

Known as: Terazosin Hydrochloride Dihydrate, terazosin hcl, terazosin, monohydrochloride, dihydrate 
The hydrochloride salt form of terazosin, a quinazoline derivative with adrenergic antagonistic property. Terazosin hydrochloride selectively… Expand
National Institutes of Health

Related topics

Related topics

11 relations
Adrenergic alpha-Antagonists [MoA]Arterial Vasodilation [PE]Decreased Blood Pressure [PE]Drug Allergy
Expand

Narrower (1)

Hytrin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Thermoanalytical investigation of terazosin hydrochloride.
PURPOSE Thermal analysis (TGA, DTG and DTA) and differential scanning calorimetry (DSC) have been used to study the thermal… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2008
2008
Acute generalized exanthematous pustulosis caused by terazosin hydrochloride.
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption mainly provoked by drugs. A case of AGEP in a 74… Expand
Is this relevant?
2007
2007
Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
BACKGROUND Terazosin is an alpha1-selective adrenoceptor blocking agent that has been reported in many clinical trials to be an… Expand
Is this relevant?
2006
2006
Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.
The phenomenon of polymorphism is prevalent in pharmaceuticals, yet it is unusual to identify more than three or four forms for… Expand
Is this relevant?
2005
2005
Infliximab for the treatment of adult-onset pityriasis rubra pilaris.
A 77-year-old man presented in June 2002 with a 2-month history of a progressive eruption that initially involved his scalp and… Expand
  • figure 1
  • figure 2
Is this relevant?
2002
2002
Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
PURPOSE For treating benign prostatic hyperplasia (BPH) 5 or 10 mg. terazosin hydrochloride daily has been routinely used in… Expand
Is this relevant?
2000
2000
Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats.
The use of electroporation pulses as a physical means of enhancing the permeability of skin to deliver drugs is in the early… Expand
Is this relevant?
1996
1996
A cost density analysis of benign prostatic hyperplasia.
We assessed the frequency and cost of care for benign prostatic hyperplasia (BPH) among approximately 165,000 subscribers to… Expand
Is this relevant?
1994
1994
Treatment-related symptoms during the first year following transperineal 125I prostate implantation.
PURPOSE To summarize the urinary, rectal, and sexual symptoms occurring during the first 12 months following 125I prostatic… Expand
Is this relevant?
1988
1988
Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
The safety and efficacy of once-daily terazosin hydrochloride administered concomitantly with once-daily atenolol for the… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE